Biotech company develops cell therapy using lymph nodes as bioreactors to grow functional organs, focusing on liver disease treatment.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
LyGenesis is a clinical-stage biotechnology company developing cell therapies that utilize patients’ lymph nodes as bioreactors to grow functioning ectopic organs. Their lead program focuses on treating end-stage liver disease by injecting donor hepatocytes into lymph nodes, promoting the growth of new liver tissue to restore organ function. This approach offers a less invasive alternative to traditional organ transplantation, potentially expanding treatment options for patients with liver failure.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
LyGenesis Management Team
LyGenesis Valuations & Financials
View real-time NPM data on LyGenesis stock including daily LyGenesis stock price estimates, valuation history, and historical share price information. Access LyGenesis financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track LyGenesis pricing across six independent market signals. Looking for private company due diligence data sources on LyGenesis? Get in touch to learn more.
Similar Companies
like LyGenesis
Cerebral
Healthcare & Life Sciences
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
ArsenalBio
Healthcare & Life Sciences
Develops programmable cell therapies for cancer patients.
Eikon Therapeutics
Healthcare & Life Sciences
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Kallyope
Healthcare & Life Sciences
Biotech company developing therapies targeting gut-brain axis interactions to treat metabolic and neurological diseases.
Clio
Healthcare & Life Sciences
Comprehensive legal practice management software designed to help law firms manage their operations more efficiently.
Array Behavioral Care
Healthcare & Life Sciences
Provider of telepsychiatry and telebehavioral health services.
Sollis Health
Healthcare & Life Sciences
Delivers personalized primary care and clinical services with a focus on patient‑centered care delivery.
Colossal Laboratories & Biosciences
Healthcare & Life Sciences
Pioneering biotech that reconstructs genomes for species restoration and ecosystem revitalization with innovative genetic engineering.
Avalyn Pharma
Healthcare & Life Sciences
Develops inhaled therapies for rare respiratory diseases like idiopathic pulmonary fibrosis and interstitial lung diseases.
FAQ
We have answers
LyGenesis stock does not trade on public stock exchanges. LyGenesis stock is considered a private security and you need to be an accredited investor to trade shares. To invest in LyGenesis stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
LyGenesis Stock does not trade on public stock exchanges. In order to sell LyGenesis shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
LyGenesis does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view LyGenesis share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for LyGenesis stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell LyGenesis stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in LyGenesis stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
LyGenesis is a private company and has not had an IPO. There is currently no LyGenesis IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to LyGenesis IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
